Overview

• Cigna posted $1.5 billion in Q2 net income on $67.2 billion in revenue, with adjusted earnings of $7.20 per share versus $7.13 expected.
• Evernorth Health Services drove growth with 17 percent higher revenue alongside a 3 percent increase in pharmacy customers year over year.
• Sales in the Cigna Healthcare segment fell 18 percent to $10.75 billion following the spring sale of the Medicare business.
• The medical cost ratio climbed to 83.2 percent due to higher stop-loss medical costs, with executives foreseeing persistent pressures into 2026.
• Management maintained its full-year adjusted income outlook of at least $29.60 per share after surpassing investor forecasts.